Conflict of interest statement: No conflicts declared
Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage
Article first published online: 8 NOV 2013
© 2013 John Wiley & Sons Ltd
Developing World Bioethics
Volume 15, Issue 1, pages 48–54, April 2015
How to Cite
Ghinea, N., Lipworth, W., Little, M., Kerridge, I. and Day, R. (2015), Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage. Developing World Bioethics, 15: 48–54. doi: 10.1111/dewb.12040
- Issue published online: 3 MAR 2015
- Article first published online: 8 NOV 2013
- 1An Introduction to Maternal Mortality. Reviews in Obstetrics and Gynecology 2008; 1: 77–81;World Health Organisation. 2012. Maternal Mortality Fact Sheet No: 348. Available at: http://www.who.int/mediacentre/factsheets/fs348/en/index.html# [Accessed 20 Sept 2013]..
- 2United Nations. 2010. Millenium Development Goals Report 2010.
- 4World Health Organisation. Maternal and Perinatel Health. Available at: http://www.who.int/reproductivehealth/topics/maternal_perinatal/epidemiology/en/ [Accessed 20 Sept 2013].
- 5United Nations, op. cit. note 2.
- 6Shortage of Healthcare Workers in Developing Countries – Africa. Ethnicity and Disease 2009; 19: S1.60–164;UNFPA. 2003. Maternal Mortality Update 2002: A Focus on Emergency Obstetric Care., et al.
- 7World Health Organisation. 2012. Trends in Maternal Mortality: 1990 to 2010. WHO, UNICEF, UNFPA and The World Bank estimates.
- 8Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews 2010; , & . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews 2010; , et al. Off-label use of misoprostol for labor induction: a nation-wide survey in Switzerland. European Journal of Obstetrics & Gynecology and Reproductive Biology 2011; 159: 324–328.& .
- 9Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Human Reproduction 2009; 34: 106–112; , et al. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion. Human Reproduction 2009; 24: 320–324., et al.
- 10Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects. Bull World Health Organ 2009; 87: 666–677; , et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. The Lancet 2010; 375: 217–223;Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. The Lancet 2010; 375: 210–216., et al.
- 11Vaginal misoprostol aids in difficult intrauterine contraceptive removal: a report of three cases. Contraception 2012; 83: 281–284;Randomised trial of oral misoprostol treatment for cervical ripening before tandem application in cervix cancer. International Journal of Radition Oncology, Biology and Physics 2011; 81: 778–781;Misoprostol prior to hysteroscopy in premenopausal and postmenopausal women. A systematic review and meta-analysis. Human Reproduction Update 2012; 18: 393–404., et al.
- 14Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012; , & . Rethinking WHO guidance: a review of evidence for misoprostol use in the prevention of postpartum haemorrhage. Journal of the Royal Society of Medicine 2012; 105: 336–347., et al.
- 16Misoprostol use in the community to reduce maternal deaths. The Lancet 2010; 376: 955;FIGO. 2012. Misoprostol for PPH in low resource settings initiative. Available at: http://www.figo.org/projects/figo-misoprostol-post-partum-haemorrhage-low-resource-settings-initiative [Accessed 20 Sept 2013]., et al.
- 18World Health Organisation. 2010. Clarifying WHO position on misoprostol use in the community to reduce maternal death. Available at: http://whqlibdoc.who.int/hq/2010/WHO_RHR_10.11_eng.pdf [Accessed 20 Sept 2013].
- 19World Health Organisation. 2013. Essential Medicines Selection. Available at: http://www.who.int/selection_medicines/committees/expert/19/applications/en/ [Accessed 20 Sept 2013].
- 201994. ‘Emerging from the data’: The cognitive processes of analysis in qualitative inquiry. In Critical issues in qualitative research methods. J.M. Morse, ed. ThousandOaks: Sage..
- 212006. Constructing grounded theory: a practical guide through qualitative analysis. London: Sage..
- 221999. Essential Ethnographic Methods. Oxford: Altamira Press., & .
- 24note 16, p. 955., et al. op. cit.
- 32Ibid: 1763.
- 35World Health Organisation, op. cit. note 18, p. 2.
- 36Aristotle. 1980. Book VI. In Nicomachean Ethics. Oxford University Press.
- 37Essentially Contested Concepts. Preceedings of the Aristotelian Society, New Series 1956; 56: 167–198..
- 40Expert Knowledge, and the Press. Washington Law Review 2012; 97: 409–443; . The Trouble With “Public Discourse” as a Limitation on Free Speech Rights. Virginia Law Review 2011; 97: 567–594.. ,
- 411991. The Structural Transformation of the Public Sphere. Cambridge, Massachusetts: The MIT Press: 144..
- 422012. The Health of Nations: Towards A New Political Economy. London: Zed Books..
- 431990. Moral Consciousness and Communicative Action. Cambridge: Polity Press..